I 

113TH CONGRESS 

1ST SESSION H. R. 2130 

To amend the Public Health Service Act to provide grants for treatment 

of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP) abuse, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 23, 2013 

Mr. CARTWRIGHT (for himself, Ms. HAHN, Mr. GRIJALVA, Mr. RANGEL, Ms. 

LEE of California, Mr. RUSH, Mr. CONYERS, Mr. RYAN of Ohio, Mr. 

HASTINGS of Florida, Ms. NORTON, Mr. CARSON of Indiana, Mr. BRADY

of Pennsylvania, Mr. HOLT, Mr. CAPUANO, Ms. SHEA-PORTER, Ms. 

MCCOLLUM, Mr. PAYNE, Mr. HUFFMAN, Mr. BEN RAY LUJA ́N of New 

Mexico, Mr. KILMER, Ms. EDDIE BERNICE JOHNSON of Texas, Ms. ROYBAL-ALLARD, and Mr. POLIS) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To amend the Public Health Service Act to provide grants 

for treatment of heroin, cocaine, methamphetamine, 3,4- 

methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP) abuse, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Access to Substance 

5 Abuse Treatment Act of 2013’’. 


pwalker on DSK7TPTVN1PROD with BILLS
2 

•HR 2130 IH

1 SEC. 2. PURPOSE. 

2 It is the purpose of this Act to— 

3 (1) reduce crime and improve public safety by 

4 making treatment for heroin, cocaine, methamphet5 amine, 3,4-methylenedioxymethamphetamine (ec6 stasy), and phencyclidine (PCP) abuse available to 

7 every American who needs it; 

8 (2) keep families together by encouraging alter9 natives to incarceration for nonviolent drug law of10 fenses; 

11 (3) help identify root causes and most effective 

12 treatment methods for heroin, cocaine, methamphet13 amine, 3,4-methylenedioxymethamphetamine, and 

14 phencyclidine abuse; and 

15 (4) expand research into cutting-edge treatment 

16 methods for stimulant abuse. 

17 SEC. 3. HEROIN, COCAINE, METHAMPHETAMINE, 3,4- 

18 METHYLENEDIOXYMETHAMPHETAMINE (EC19 STASY), AND PHENCYCLIDINE (PCP) TREAT20 MENT AND WRAP-AROUND PROGRAMS. 

21 Subpart 1 of part B of title V of the Public Health 

22 Service Act is amended— 

23 (1) redesignating the second section 514 (relat24 ing to methamphetamine and amphetamine treat25 ment) as section 514B; and 


pwalker on DSK7TPTVN1PROD with BILLS
3 

•HR 2130 IH

1 (2) adding at the end the following new sec2 tions: 

3 ‘‘SEC. 514C. INITIATIVE TO INCREASE HEROIN, COCAINE, 

4 METHAMPHETAMINE, ECSTASY, AND PCP 

5 TREATMENT CAPACITY. 

6 ‘‘(a) IN GENERAL.—The Secretary may make grants 

7 to State, local, and tribal governments for the purpose of 

8 increasing the availability of treatment for heroin, cocaine, 

9 methamphetamine, 3,4-methylenedioxymethamphetamine 

10 (ecstasy), and phencyclidine (PCP) abuse. 

11 ‘‘(b) REQUIREMENTS.— 

12 ‘‘(1) IN GENERAL.—To seek a grant under sub13 section (a), a State, local, or tribal government shall 

14 submit an application to the Secretary at such time, 

15 in such manner, and containing such information 

16 and assurances as the Secretary may require. 

17 ‘‘(2) USE OF GRANT FUNDS.—The grants made 

18 under subsection (a) may only be used to— 

19 ‘‘(A) build treatment centers; 

20 ‘‘(B) expand existing treatment centers; 

21 ‘‘(C) hire treatment professionals; 

22 ‘‘(D) provide training and education to 

23 substance abuse professionals, medical profes24 sionals, and educators related to the treatment 

25 of heroin, cocaine, methamphetamine, 3,4- 


pwalker on DSK7TPTVN1PROD with BILLS
4 

•HR 2130 IH

1 methylenedioxymethamphetamine, and phency2 clidine abuse; and 

3 ‘‘(E) engage in other activities that the 

4 Secretary has determined are relevant to the 

5 purpose of the grants under subsection (a). 

6 ‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There 

7 are authorized to be appropriated such sums as may be 

8 necessary to carry out this section for fiscal years 2014 

9 through 2018. 

10 ‘‘SEC. 514D. HEROIN, COCAINE, METHAMPHETAMINE, EC11 STASY, AND PCP ABUSE TREATMENT VOUCH12 ERS FOR UNDERSERVED POPULATIONS. 

13 ‘‘(a) IN GENERAL.—The Secretary may make grants 

14 to State, local, and tribal governments and nonprofit enti15 ties to provide vouchers to individuals in underserved pop16 ulations for authorized services related to the treatment 

17 of such individuals for heroin, cocaine, methamphetamine, 

18 3,4-methylenedioxymethamphetamine (ecstasy), and phen19 cyclidine (PCP) abuse. 

20 ‘‘(b) REQUIREMENTS.— 

21 ‘‘(1) APPLICATION.—To seek a grant under 

22 subsection (a), a State, local, or tribal government 

23 or a nonprofit entity shall submit an application to 

24 the Secretary at such time, in such manner, and 

25 containing such information and assurances as the 


pwalker on DSK7TPTVN1PROD with BILLS
5 

•HR 2130 IH

1 Secretary may require, including a description of the 

2 method that such State, government, or entity will 

3 use— 

4 ‘‘(A) to identify individuals who would ben5 efit from treatment for heroin, cocaine, meth6 amphetamine, 3,4-methylenedioxymethamphet7 amine, or phencyclidine abuse; 

8 ‘‘(B) to identify if such individuals are in 

9 underserved populations; and 

10 ‘‘(C) to provide vouchers to such individ11 uals in such populations. 

12 ‘‘(2) PRESERVATION OF CHOICE.—A recipient 

13 of a grant under this section may not restrict the 

14 ability of an individual receiving a voucher under 

15 this section to use the voucher to pay for authorized 

16 services furnished by any provider of authorized 

17 services, so long as the provider of such services 

18 meets all applicable State licensure or certification 

19 requirements regarding the provision of such serv20 ices. 

21 ‘‘(3) DURATION OF AWARD.—With respect to a 

22 grant under this section, the period during which 

23 payments under such grant are made to the grant 

24 recipient may not exceed five years. 


pwalker on DSK7TPTVN1PROD with BILLS
6 

•HR 2130 IH

1 ‘‘(4) MATCHING FUNDS.—The Secretary may 

2 require that recipients of grants under this section 

3 provide non-Federal matching funds, as determined 

4 appropriate by the Secretary, to ensure the commit5 ment of the grant recipients to the provision of 

6 vouchers for treatment to individuals who use her7 oin, cocaine, methamphetamine, 3,4-methylenedioxy8 methamphetamine, or phencyclidine. Such non-Fed9 eral matching funds may be provided directly or 

10 through donations from public or private entities 

11 and may be in cash or in-kind, fairly evaluated, in12 cluding property, equipment, or services. 

13 ‘‘(5) MAINTENANCE OF EFFORT.—The Sec14 retary may require that grant recipients under this 

15 section agree to maintain expenditures of non-Fed16 eral amounts for authorized services related to the 

17 treatment of heroin, cocaine, methamphetamine, 3,4- 

18 methylenedioxymethamphetamine, and phencyclidine 

19 abuse at a level that is not less than the level of 

20 such expenditures maintained by the recipient for 

21 the fiscal year preceding the fiscal year for which 

22 the entity receives such a grant. 

23 ‘‘(c) REPORT.— 

24 ‘‘(1) IN GENERAL.—Not later than December 1, 

25 2014, and annually thereafter, the Secretary shall 


pwalker on DSK7TPTVN1PROD with BILLS
7 

•HR 2130 IH

1 submit a report to the Congress on the grants under 

2 subsection (a). 

3 ‘‘(2) CONTENTS OF REPORT.—The report under 

4 paragraph (1) shall contain an evaluation of the ef5 fectiveness of the grants made under subsection (a) 

6 in improving access to heroin, cocaine, methamphet7 amine, 3,4-methylenedioxymethamphetamine, and 

8 phencyclidine treatment for underserved populations. 

9 ‘‘(d) DEFINITIONS.—For purposes of this section: 

10 ‘‘(1) AUTHORIZED SERVICES.—The term ‘au11 thorized services’ means— 

12 ‘‘(A) treatment for heroin, cocaine, meth13 amphetamine, 3,4-methylenedioxymethamphet14 amine, or phencyclidine abuse, including indi15 vidual, group, and family counseling regarding 

16 such abuse; 

17 ‘‘(B) follow-up services to prevent an indi18 vidual from relapsing into such abuse; 

19 ‘‘(C) wrap-around services, as such term is 

20 defined in section 514E(e)(4); and 

21 ‘‘(D) any additional services specified by 

22 the Secretary. 

23 ‘‘(2) UNDERSERVED POPULATION.—The term 

24 ‘underserved population’ means a population of indi25 viduals who cannot access appropriate substance 


pwalker on DSK7TPTVN1PROD with BILLS
8 

•HR 2130 IH

1 abuse treatment (including comprehensive substance 

2 abuse treatment) due to financial, geographical, lan3 guage, socioeconomic, or cultural barriers. 

4 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 

5 are authorized to be appropriated such sums as may be 

6 necessary to carry out this section for fiscal years 2014 

7 through 2018. 

8 ‘‘SEC. 514E. COMPREHENSIVE WRAP-AROUND HEROIN, CO9 CAINE, METHAMPHETAMINE, 3,4-METHYLENE10 DIOXYMETHAMPHETAMINE (ECSTASY), AND 

11 PHENCYCLIDINE (PCP) TREATMENT SERV12 ICES. 

13 ‘‘(a) IN GENERAL.—The Secretary may make grants 

14 to public, private, and nonprofit entities, Indian tribes, 

15 and tribal organizations to establish programs to provide 

16 for and coordinate the provision of wrap-around services 

17 to heroin, cocaine, methamphetamine, 3,4-methylenedioxy18 methamphetamine, or phencyclidine-affected individuals. 

19 ‘‘(b) MINIMUM QUALIFICATIONS FOR RECEIPT OF

20 AWARD.—To seek a grant under subsection (a), a public, 

21 private, or nonprofit entity, an Indian tribe, or a tribal 

22 organization shall submit an application to the Secretary 

23 at such time, in such manner, and containing such infor24 mation and assurances as the Secretary may require, inVerDate Mar 15 2010 23:32 May 30, 2013 Jkt 029200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H2130.IH H2130

pwalker on DSK7TPTVN1PROD with BILLS
9 

•HR 2130 IH

1 cluding assurances to the satisfaction of the Secretary 

2 that— 

3 ‘‘(1) the applicant has the capacity to carry out 

4 a program described in subsection (a); 

5 ‘‘(2) the applicant has entered into agreements 

6 with entities in the community involved, through 

7 which the applicant will provide wrap-around serv8 ices; and 

9 ‘‘(3) the applicant, or any entity through which 

10 the applicant will provide such services, meets all ap11 plicable State licensure or certification requirements 

12 regarding the provision of such services. 

13 ‘‘(c) PRIORITY FOR GRANT DISTRIBUTION.—In mak14 ing grants under this section, the Secretary shall give pri15 ority to applications for programs that serve communities 

16 with a high or increasing rate of heroin, cocaine, meth17 amphetamine, 3,4-methylenedioxymethamphetamine, or 

18 phencyclidine abuse or addiction, as specified by the Sec19 retary. 

20 ‘‘(d) REPORTS.—For each year that a public, private, 

21 or nonprofit entity, Indian tribe, or tribal organization re22 ceives a grant under subsection (a) for a program, such 

23 entity, tribe, or organization shall submit to the Secretary 

24 a report on the results and effectiveness of the program. 

25 ‘‘(e) DEFINITIONS.—For purposes of this section: 


pwalker on DSK7TPTVN1PROD with BILLS
10 

•HR 2130 IH

1 ‘‘(1) HEROIN, COCAINE, METHAMPHETAMINE, 

2 3,4-METHYLENEDIOXYMETHAMPHETAMINE, OR

3 PHENCYCLIDINE-AFFECTED INDIVIDUAL.—The term 

4 ‘heroin, cocaine, methamphetamine, 3,4-methylene5 dioxymethamphetamine, or phencyclidine-affected in6 dividual’ means an individual who— 

7 ‘‘(A)(i) resided in a residential inpatient 

8 treatment facility for the treatment of heroin, 

9 cocaine, methamphetamine, 3,4-methylenedioxy10 methamphetamine, or phencyclidine abuse or 

11 addiction; or 

12 ‘‘(ii) received treatment for heroin, cocaine, 

13 methamphetamine, 3,4-methylenedioxymetham14 phetamine, or phencyclidine abuse or addiction 

15 from an intensive outpatient treatment facility; 

16 and 

17 ‘‘(B) after successful completion of such 

18 treatment reenters the community. 

19 ‘‘(2) INTENSIVE OUTPATIENT TREATMENT FA20 CILITY.—The term ‘intensive outpatient treatment 

21 facility’ means a facility that provides treatment for 

22 substance abuse and that, with respect to an indi23 vidual receiving such treatment— 

24 ‘‘(A) provides a minimum of seven hours of 

25 treatment for substance abuse during a week; 


pwalker on DSK7TPTVN1PROD with BILLS
11 

•HR 2130 IH

1 ‘‘(B) provides regularly scheduled treat2 ment sessions within a structured program; and 

3 ‘‘(C) ensures that the treatment sessions 

4 are led by health professionals or clinicians. 

5 ‘‘(3) RESIDENTIAL INPATIENT TREATMENT FA6 CILITY.—The term ‘residential inpatient treatment 

7 facility’ means a facility that provides treatment for 

8 substance abuse in which health professionals and 

9 clinicians provide a planned regimen of 24-hour pro10 fessionally directed evaluation, care, and treatment 

11 for such substance abuse in an inpatient setting, in12 cluding 24-hour observation and monitoring. 

13 ‘‘(4) WRAP-AROUND SERVICES.—The term 

14 ‘wrap-around services’ means, with respect to a her15 oin, cocaine, methamphetamine, 3,4-methylenedioxy16 methamphetamine, or phencyclidine-affected indi17 vidual, the following services: 

18 ‘‘(A) Medical services. 

19 ‘‘(B) Dental services. 

20 ‘‘(C) Mental health services. 

21 ‘‘(D) Child care services. 

22 ‘‘(E) Job training services. 

23 ‘‘(F) Housing assistance. 

24 ‘‘(G) Training in parenting. 


pwalker on DSK7TPTVN1PROD with BILLS
12 

•HR 2130 IH

1 ‘‘(H) Prevention services for family mem2 bers, with respect to heroin, cocaine, meth3 amphetamine, 3,4-methylenedioxymethamphet4 amine, and phencyclidine abuse or addiction. 

5 ‘‘(I) Transportation assistance services for 

6 purposes of participation in the services listed 

7 in subparagraphs (A) through (H). 

8 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 

9 are authorized to be appropriated such sums as may be 

10 necessary to carry out this section for fiscal years 2014 

11 through 2018.’’. 

12 SEC. 4. EXTENSION AND EXPANSION OF RESIDENTIAL 

13 TREATMENT PROGRAM FOR PREGNANT AND 

14 POSTPARTUM WOMEN TO INCLUDE CARE15 GIVER PARENTS. 

16 Section 508 of the Public Health Service Act (42 

17 U.S.C. 290bb–1) is amended— 

18 (1) in the heading, by striking ‘‘PREGNANT AND

19 POSTPARTUM WOMEN’’ and inserting ‘‘CAREGIVER

20 PARENTS, INCLUDING PREGNANT WOMEN’’; 

21 (2) in subsection (a)— 

22 (A) in the matter preceding paragraph 

23 (1)— 


pwalker on DSK7TPTVN1PROD with BILLS
13 

•HR 2130 IH

1 (i) by inserting ‘‘, Indian tribes, and 

2 tribal organizations’’ after ‘‘nonprofit pri3 vate entities’’; and 

4 (ii) by striking ‘‘pregnant and 

5 postpartum women treatment for sub6 stance abuse’’ and inserting ‘‘caregiver 

7 parents, including pregnant women, treat8 ment for substance abuse (including treat9 ment for addiction to heroin, cocaine, 

10 methamphetamine, 3,4-methylenedioxy11 methamphetamine (ecstasy), or phencycli12 dine (PCP))’’; 

13 (B) in each of paragraphs (1), (2), and 

14 (3), by striking ‘‘the women’’ and inserting 

15 ‘‘such parents’’ each place it appears; and 

16 (C) in paragraph (3), by inserting ‘‘supple17 mental’’ before ‘‘services’’; 

18 (3) in subsection (b)— 

19 (A) in paragraph (1), by inserting ‘‘, In20 dian tribes, or tribal organizations’’ after ‘‘non21 profit private entities’’; and 

22 (B) in paragraph (2)— 

23 (i) by striking ‘‘the services’’ and in24 serting ‘‘such services’’; and 


pwalker on DSK7TPTVN1PROD with BILLS
14 

•HR 2130 IH

1 (ii) by striking ‘‘woman’’ and insert2 ing ‘‘caregiver parent’’; 

3 (4) in subsection (c)— 

4 (A) in paragraph (1), by striking ‘‘eligible 

5 woman’’ and inserting ‘‘eligible caregiver par6 ent’’; and 

7 (B) by striking ‘‘the women’’ and ‘‘the 

8 woman’’ each place either term appears and in9 serting ‘‘such parent’’; 

10 (5) in subsection (d)— 

11 (A) in the matter proceeding paragraph 

12 (1), by striking ‘‘woman’’ and inserting ‘‘care13 giver parent’’; 

14 (B) in paragraphs (3) and (4), by striking 

15 ‘‘the woman’’ and inserting ‘‘such parent’’ each 

16 place it appears; 

17 (C) in paragraph (9)— 

18 (i) by striking ‘‘the women’’ and in19 serting ‘‘such parent’’ each place it ap20 pears; 

21 (ii) by striking ‘‘units’’ and inserting 

22 ‘‘unit’’; and 

23 (iii) by striking ‘‘of parents’’ and in24 serting ‘‘of the parents of such parent’’; 


pwalker on DSK7TPTVN1PROD with BILLS
15 

•HR 2130 IH

1 (D) in paragraph (10), by inserting ‘‘, In2 dian tribes, or tribal organizations’’ after ‘‘enti3 ties’’; and 

4 (E) in paragraph (11)— 

5 (i) by striking ‘‘the women’’ and in6 serting ‘‘such parent’’; and 

7 (ii) by striking ‘‘their children’’ and 

8 inserting ‘‘the children of such parent’’; 

9 (6) in subsection (f)(1), in the matter pro10 ceeding subparagraph (A) by inserting ‘‘, Indian 

11 tribes, or tribal organizations’’ after ‘‘public or pri12 vate entities’’; 

13 (7) in subsection (g)— 

14 (A) by striking ‘‘identify women’’ and in15 serting ‘‘identify caregiver parents’’; and 

16 (B) by striking ‘‘the women’’ and inserting 

17 ‘‘such parents’’; 

18 (8) in subsection (h)(1), by striking ‘‘pregnant 

19 and postpartum women’’ and inserting ‘‘caregiver 

20 parents’’; 

21 (9) in subsection (j)— 

22 (A) in the matter proceeding paragraph 

23 (1)— 

24 (i) by striking ‘‘to on behalf’’ and in25 serting ‘‘to or on behalf’’; and 


pwalker on DSK7TPTVN1PROD with BILLS
16 

•HR 2130 IH

1 (ii) by striking ‘‘woman’’ and insert2 ing ‘‘caregiver parent’’; 

3 (B) in paragraph (2), by striking ‘‘the 

4 woman’’ and inserting ‘‘such parent’’; and 

5 (C) in paragraph (3), by striking ‘‘woman’’ 

6 and inserting ‘‘parent’’; 

7 (10) in subsection (k)(2), by striking ‘‘women’’ 

8 and inserting ‘‘caregiver parents’’— 

9 (11) in subsection (l), by striking ‘‘such agree10 ments’’ and inserting ‘‘the funding agreements 

11 under this section’’; 

12 (12) by amending subsection (m) to read as fol13 lows: 

14 ‘‘(m) USE OF FUNDS; PRIORITY FOR CERTAIN

15 AREAS SERVED.— 

16 ‘‘(1) USE OF FUNDS.—A funding agreement for 

17 an award under subsection (a) for an applicant is 

18 that funds awarded under subsection (a) to such ap19 plicant shall be used for programs according to the 

20 following order of priority: 

21 ‘‘(A) For a program that provides services 

22 to caregiver parents who are pregnant and 

23 postpartum women. 

24 ‘‘(B) For a program that provides services 

25 to caregiver parents who are single parents and 


pwalker on DSK7TPTVN1PROD with BILLS
17 

•HR 2130 IH

1 the sole caregivers with respect to their chil2 dren. 

3 ‘‘(C) For a program that provides services 

4 to any caregiver parents. 

5 ‘‘(2) PRIORITY FOR CERTAIN AREAS SERVED.— 

6 In making awards under subsection (a), the Director 

7 shall give priority to any entity, tribe, or organiza8 tion that agrees to use the award for a program 

9 serving an area that— 

10 ‘‘(A) is an area determined by the Director 

11 to have a shortage of family-based substance 

12 abuse treatment options; or 

13 ‘‘(B) is determined by the Director to have 

14 high rates of addiction to heroin, cocaine, meth15 amphetamine, 3,4-methylenedioxymethamphet16 amine, or phencyclidine.’’; 

17 (13) in subsection (p)— 

18 (A) by striking ‘‘October 1, 1994’’ and in19 serting ‘‘January 1, 2014’’; 

20 (B) by striking ‘‘Committee on Labor and 

21 Human Resources’’ and inserting ‘‘Committee 

22 on Health, Education, Labor, and Pensions’’; 

23 and 

24 (C) by striking the third sentence; 

25 (14) in subsection (q)— 


pwalker on DSK7TPTVN1PROD with BILLS
18 

•HR 2130 IH

1 (A) by redesignating paragraphs (2), (3), 

2 (4), and (5) as paragraphs (3), (4), (5), and 

3 (6), respectively; 

4 (B) by inserting after paragraph (1) the 

5 following new paragraph: 

6 ‘‘(2) The term ‘caregiver parent’ means, with 

7 respect to a child, a parent or legal guardian with 

8 whom the child resides, and includes a pregnant 

9 woman.’’; and 

10 (C) by amending paragraph (3), as redes11 ignated by subparagraph (A) of this paragraph, 

12 to read as follows: 

13 ‘‘(3) The term ‘eligible caregiver parent’ means 

14 a caregiver parent who has been admitted to a pro15 gram operated pursuant to subsection (a).’’; and 

16 (15) in subsection (r), by striking ‘‘to fiscal 

17 years 2001 through 2003’’ and inserting ‘‘for fiscal 

18 years 2014 through 2018’’. 

19 SEC. 5. EFFECTIVENESS OF STIMULANT TREATMENT 

20 METHODS. 

21 (a) RESEARCH.—The Director of the National Insti22 tute on Drug Abuse shall conduct research, directly or 

23 through contract with another entity, on the effectiveness 

24 of the use of agonist and antagonist drugs to reduce the 


pwalker on DSK7TPTVN1PROD with BILLS
19 

•HR 2130 IH

1 problems associated with stimulant abuse, including co2 caine and methamphetamine abuse. 

3 (b) AUTHORIZATION OF APPROPRIATIONS.—There 

4 are authorized to be appropriated such sums as may be 

5 necessary to carry out this section for fiscal years 2014 

6 through 2018. 

7 SEC. 6. IOM STUDY ON DRUG TREATMENTS FOR STIMU8 LANT ABUSE. 

9 (a) REPORT.—The Secretary of Health and Human 

10 Services shall seek to enter into a contract with the Insti11 tute of Medicine of the National Academies to complete 

12 a literature review and submit a report to Congress on 

13 the effectiveness of agonist and antagonist drugs for the 

14 treatment of stimulant abuse, including cocaine and meth15 amphetamine abuse. 

16 (b) AUTHORIZATION OF APPROPRIATIONS.—There 

17 are authorized to be appropriated such sums as may be 

18 necessary to carry out this section for fiscal years 2014 

19 through 2018. 

20 SEC. 7. GAO EVALUATION OF THE IMPACT OF THIS LEGIS21 LATION. 

22 (a) STUDY ON THE LEVEL OF FUNDING FOR TREAT23 MENT.—The Comptroller General of the United States 

24 shall conduct a study on— 


pwalker on DSK7TPTVN1PROD with BILLS
20 

•HR 2130 IH

1 (1) the impact of the programs authorized by 

2 this Act (including the amendments made by this 

3 Act) on the effectiveness and availability of treat4 ment for heroin, cocaine, methamphetamine, 3,4- 

5 methylenedioxymethamphetamine, and phencyclidine 

6 abuse; 

7 (2) whether the level of Federal funding avail8 able for the treatment of heroin, cocaine, meth9 amphetamine, 3,4-methylenedioxymethamphetamine, 

10 and phencyclidine abuse meets, exceeds, or is less 

11 than the amount necessary to provide adequate 

12 treatment for such abuse; and 

13 (3) the impact of effective treatment of heroin, 

14 cocaine, methamphetamine, 3,4-methylenedioxymeth15 amphetamine, and phencyclidine abuse on cost sav16 ings due to the reduced need for criminal justice and 

17 other services. 

18 (b) REPORTS.— 

19 (1) INTERIM REPORT.—Not later than the last 

20 day of the two-year period beginning on the date of 

21 enactment of this Act, the Comptroller General shall 

22 submit to Congress a report on the interim findings 

23 of the study under subsection (a). 

24 (2) FINAL REPORT.—Not later than 3 years 

25 after the date on which the report under paragraph 


pwalker on DSK7TPTVN1PROD with BILLS
21 

•HR 2130 IH

1 (1) is submitted to Congress, the Comptroller Gen2 eral shall submit to Congress a report on the find3 ings of the study under subsection (a). 

4 SEC. 8. NO ADDITIONAL APPROPRIATIONS. 

5 This Act, and the amendments made by this Act, 

6 shall not be construed to increase the amount of appro7 priations that are authorized to be approved for any fiscal 

8 year. 

Æ 


pwalker on DSK7TPTVN1PROD with BILLS